halothane has been researched along with Chronic Hepatitis B in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Patients with hepatocellular carcinoma with cirrhosis required intermediate end-tidal isoflurane concentrations; healthy live liver donors required the highest end-tidal isoflurane concentrations to provide sufficient anesthetic depth, as monitored by a target BIS (range, 45-55)." | 1.35 | Bispectral index monitoring in healthy, cirrhotic, and end-stage liver disease patients undergoing hepatic operation. ( Chen, CL; Chen, KH; Cheng, KW; Cheng, YF; Chiu, KW; Concejero, AM; Huang, CJ; Huang, TL; Jawan, B; Lin, CC; Liu, YW; Wang, CC; Wang, CH; Wang, SH, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, CH | 1 |
Chen, CL | 1 |
Cheng, KW | 1 |
Huang, CJ | 1 |
Chen, KH | 1 |
Wang, CC | 1 |
Concejero, AM | 1 |
Cheng, YF | 1 |
Huang, TL | 1 |
Chiu, KW | 1 |
Wang, SH | 1 |
Lin, CC | 1 |
Liu, YW | 1 |
Jawan, B | 1 |
1 other study available for halothane and Chronic Hepatitis B
Article | Year |
---|---|
Bispectral index monitoring in healthy, cirrhotic, and end-stage liver disease patients undergoing hepatic operation.
Topics: Adult; Aged; Anesthesia, Inhalation; Carcinoma, Hepatocellular; Halothane; Hepatitis B, Chronic; Hum | 2008 |